Varaico: Literature-Extracted Genetic Variants

Gene:MDM2
Variant:p.S155Y
Back to variants list

MDM2

NM_002392.6:p.S155Y

Associated Papers

FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p53.

Haferssas D et al.

Oncogenesis, 2025

MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner.

Fefilova E et al.

Biochemical and Biophysical Research Communications, 2025

Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus.

Ni Y et al.

Experimental Cell Research, 2024

USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression.

Liu X et al.

Molecular Oncology, 2024

Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis.

Lien S et al.

American Journal of Cancer Research, 2024

The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.

Hu H et al.

Cell Reports, 2023

MDM2-Mediated Ubiquitination of RXRβ Contributes to Mitochondrial Damage and Related Inflammation in Atherosclerosis.

Zeng Y et al.

International Journal of Molecular Sciences, 2022

MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.

Chinnam M et al.

Plos Genetics, 2022

The miR-19b-3p-MAP2K3-STAT3 feedback loop regulates cell proliferation and invasion in esophageal squamous cell carcinoma.

Zhang Y et al.

Molecular Oncology, 2021

The Ras-ERK signaling pathway regulates acetylated activating transcription factor 2 via p300 in pancreatic cancer cells.

Li M et al.

Annals of Translational Medicine, 2020

Single-Chain Lanthanide Luminescence Biosensors for Cell-Based Imaging and Screening of Protein-Protein Interactions.

Chen T et al.

Iscience, 2020

33083762 (PubMed )
Supplement: mmc1.pdf

MDM2's dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities.

Gnanasundram SV et al.

Nucleic Acids Research, 2020

Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma.

Cissé MY et al.

Science Translational Medicine, 2020

Ribosomal protein S2 interplays with MDM2 to induce p53.

Cho J et al.

Biochemical and Biophysical Research Communications, 2020

Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.

Wang A et al.

Frontiers in Immunology, 2020

A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance.

Wang W et al.

Genes & Diseases, 2019

Hsp90β interacts with MDM2 to suppress p53-dependent senescence during skeletal muscle regeneration.

He MY et al.

Aging Cell, 2019

MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network.

Elkholi R et al.

Molecular Cell, 2019

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence.

Xu X et al.

Cell Death & Disease, 2019

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize.

Kosztyu P et al.

Frontiers in Physiology, 2019

Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53.

Arena G et al.

Molecular Cell, 2018

Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Zhao K et al.

Embo Reports, 2018

Activation of p53 and destabilization of androgen receptor by combinatorial inhibition of MDM2 and MDMX in prostate cancer cells.

Chopra H et al.

Oncotarget, 2018

Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.

Tian H et al.

The Journal of Biological Chemistry, 2017

Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.

Senturk JC et al.

Oncogene, 2017

Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.

Cao B et al.

Oncotarget, 2017

Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.

Nomura K et al.

Nature Structural & Molecular Biology, 2017

Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature.

Nandikolla AG et al.

Breast Cancer (dove Medical Press), 2017

Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.

Chao T et al.

Nature Communications, 2016

Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Carr MI et al.

Translational Cancer Research, 2016

Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.

Riscal R et al.

Molecular Cell, 2016

RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.

Gao K et al.

Cancer Letters, 2016

Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.

Frum RA et al.

Molecular Cancer Research : Mcr, 2016

NORE1A Regulates MDM2 Via β-TrCP.

Schmidt ML et al.

Cancers, 2016

Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation.

Yu ZC et al.

Nucleic Acids Research, 2016

26531827 (PubMed )
Supplement: supp_gkv1173_nar-01758-d-2015-File003.pdf

The p53-Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans.

Coffill CR et al.

Genes & Development, 2016

MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.

Wienken M et al.

Molecular Cell, 2016

Regulation of MDM2 Stability After DNA Damage.

Li J et al.

Journal of Cellular Physiology, 2015

Functional interplay between MDM2, p63/p73 and mutant p53.

Stindt MH et al.

Oncogene, 2015

MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition.

Kovatcheva M et al.

Oncotarget, 2015

Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.

Xu C et al.

Oncogene, 2015

The alternative translated MDMX(p60) isoform regulates MDM2 activity.

Tournillon AS et al.

Cell Cycle (georgetown, Tex.), 2015

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.

Marcar L et al.

Plos One, 2015

MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner.

Joshi S et al.

The Journal of Biological Chemistry, 2014

HDMX folds the nascent p53 mRNA following activation by the ATM kinase.

Malbert-Colas L et al.

Molecular Cell, 2014

1–50 of 108 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."